Morning Overview on MSN
A cancer drug just became the first FDA-cleared treatment for a common breast-cancer subtype
Patients with the most common molecular subtype of advanced breast cancer now have a targeted drug approved specifically for ...
The Food and Drug Administration on Thursday announced the first round of experimental drugs that will receive drastically expedited reviews at the agency, part of an effort to prioritize medicines ...
Treatments for fibrodysplasia ossificans progressiva, gastroenteropancreatic neuroendocrine tumors, HIV, influenza, and multiple myeloma are under review.
Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results